Inclusion of the Orphan Cures Act in the One Big Beautiful Bill legislation implies that certain high-cost drugs with orphan indications will either no longer be eligible for Medicare price negotiation or will have their eligibility deferred.
Inclusion of the Orphan Cures Act in the One Big Beautiful Bill legislation implies that certain high-cost drugs with orphan indications will either no longer be eligible for Medicare price negotiation or will have their eligibility deferred.